Synthroid should not be used as a synthroid federal reporter or adjunctive therapy in a weight control program. To be sure synthroid federal reporter medicine is helping your condition, your blood will need to be tested often. Do not discontinue or change the amount you take or how often you take it, unless directed to do so by your physician. What should I discuss with my healthcare provider before taking levothyroxine? Since thyroid hormone occurs naturally in the body, almost anyone can take levothyroxine. This list is not complete and there are many other drugs that can interact with levothyroxine. Drugs that may alter T4 and T3 serum transport - but FT4 concentration remains normal; and therefore, the patient remains euthyroid Drugs that may increase serum TBG concentration Drugs that may decrease serum TBG concentration Clofibrate Estrogen-containing oral contraceptives Estrogens (oral) Heroin / Methadone 5-Fluorouracil Mitotane Tamoxifen Androgens / Anabolic Steroids Asparaginase Glucocorticoids Slow-Release Nicotinic Acid Drugs that may cause protein-binding site displacement Furosemide (> 80 mg IV) Heparin Hydantoins Non Steroidal Anti-Inflammatory Drugs - Fenamates - Phenylbutazone Salicylates (> 2 g/day) Administration of these agents with levothyroxine results in an initial transient increase in FT4.
synthroid history of problems 2008
Overdose symptoms may include chest pain, pounding heartbeat, tremor, shortness of breath, leg cramps, confusion, vomiting, diarrhea, or seizures. Effects on synthroid federal reporter Mineral Density In women, long-term levothyroxine sodium therapy has been associated with increased bone resorption, thereby decreasing bone mineral density, especially in post-menopausal women on greater than replacement doses or in women who are receiving suppressive doses of levothyroxine sodium. It does not contain all information about Synthroid. The metabolic actions of thyroid hormones include augmentation of cellular respiration and thermogenesis, as well as metabolism of proteins, carbohydrates and lipids. Take Synthroid as a single dose, preferably on an empty stomach, one-half to one hour before breakfast. Every effort has been made to ensure that the information provided by Cerner Multum, Inc. Overtreatment with levothyroxine sodium may have adverse cardiovascular effects such as an increase in heart rate, cardiac wall thickness, and cardiac contractility and may precipitate synthroid federal reporter or arrhythmias. It synthroid federal reporter important to take Synthroid exactly as prescribed. Newborns The synthroid federal reporter starting dose of levothyroxine sodium in newborn infants is 10-15 mcg/kg/day . Synthroid may cause seizures at the beginning of treatment, although this is rare. This may not be a complete list of all interactions that synthroid federal reporter occur. . Due to the long half-life of levothyroxine, the peak therapeutic effect at a given dose of levothyroxine sodium may not be attained for 4-6 weeks. This drug does synthroid federal reporter into breast milk, but it is not expected to be harmful to a nursing infant. It is very important to take levothyroxine with a full glass (8 ounces) of water. In patients with severe hypothyroidism, the recommended initial levothyroxine sodium dose is 12.5-25 mcg/day with increases of 25 mcg/day every 2-4 weeks, accompanied by clinical and laboratory assessment, until the TSH level is normalized. If your brand may cause these effects, be sure to take your medicine with a full glass of water. It is very important to take levothyroxine with a full glass (8 ounces) of water. 6 Product Characteristics Color YELLOW Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;100 Contains synthroid federal reporter # NDC Package Description Multilevel Packaging 1 0074-6624-13 100 TABLET In 1 BOTTLE None 2 0074-6624-19 1000 TABLET In 1 BOTTLE None 3 0074-6624-11 10 BLISTER PACK In 1 synthroid federal reporter UNIT-DOSE contains a BLISTER PACK 3 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-6624-11) Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date synthroid federal reporter End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN synthroid federal reporter DRUG NDC Product Code (Source) 0074-6594 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 88 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C BLUE NO. How to use Synthroid: Use Synthroid as directed by your doctor.
The recommended starting dose of levothyroxine sodium in elderly patients with cardiac disease is 12.5-25 mcg/day , with gradual dose increments at 4-6 week intervals. Even if you feel well, you may still need to take this medicine every day for the rest of your life to replace the thyroid hormone your body cannot produce. Although there has been a reported association between prolonged thyroid hormone therapy and breast cancer, this has synthroid federal reporter been confirmed. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Do not switch to another brand of levothyroxine without consulting your doctor. No COMMON side effects have been reported with the use of Synthroid. Seizures have been reported rarely synthroid federal reporter the institution of levothyroxine therapy. This list is not complete and there are many other drugs that can interact with Synthroid. Since postpartum TSH levels are similar to preconception values, the Synthroid dosage should return to the pre-pregnancy dose immediately after delivery. Drug Interactions Many drugs affect thyroid hormone pharmacokinetics and metabolism (e.g., absorption, synthesis, secretion, catabolism, protein binding, and target tissue response) and may alter the therapeutic response to Synthroid. Urinary excretion of T4 decreases with age. The physiological actions of thyroid hormones are produced predominantly by T3, the majority of which (approximately 80%) is derived from T4 by deiodination in peripheral tissues. . Many drugs and physiologic conditions affect the binding of thyroid hormones to serum proteins (see PRECAUTIONS - Drug Interactions and Drug-Laboratory Test Interactions).